CANCER SCAN (828978)

  https://cordis.europa.eu/project/id/828978

  Horizon 2020 (2014-2020)

  A Body Scan for Cancer Detection using Quantum Technology

  FET-Open Challenging Current Thinking (FETOPEN-01-2018-2019-2020)

  breast cancer  ·  mutation  ·  quantum optics  ·  photons  ·  mathematical model

  2019-01-01 Start Date (YY-MM-DD)

  2023-12-31 End Date (YY-MM-DD)

  € 3,934,743 Total Cost


  Description

We propose to develop a radically new unified technological concept of biomedical detection utilizing front line new ideas in quantum optics and quantum mechanics. The new concept will be based on unified transmission and detection of photons in a three dimensional space of orbital angular momentum, entanglement and hyper-spectral characteristics (OES). These will enable a revolutionary scanner capable of detecting cancer not only in a specified organ but in various parts of the body at once, even from remote locations, and with no radiation risk whatsoever. Our pilot project will be focused on the early detection of breast cancer. Mammography, as the state of the art method for breast cancer screening, is limited in its sensitivity especially in younger women and/or women with dense breasts, and has been found to be problematic in women with genetic mutations. Thus the development of an improved and more reliable detection method is of paramount importance. A novel detection algorithm will be developed based on clinical trials in breast cancer patients, using the unified transmission and detection theory. We chose to verify our concept in the area of breast cancer due to its prevalence and the condition that feeds our concept (large amount of tissue without bone). In the long term this approach can be adapted to other areas of bio-medical diagnostics leading to total mass screening. The concept is based on non invasive utilization of light and its ramifications are numerous. In the proposed project, the endeavor will be both theoretical and experimental including derivation of a mathematical model and development of an experimental bio-compatible test-bed for cancer detection with minimal false positives. Our joint knowledge places the project at the cutting edge of science and technology developing a novel technology with the long-term vision of integrating quantum science in medical applications.


  Complicit Organisations

1 Israeli organisation participates in CANCER SCAN.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Austria MEDIZINISCHE UNIVERSITAET WIEN (999989976) ATU57469858 participant HES € 579,151 € 579,151 € 579,151
Germany TECHNISCHE UNIVERSITAET MUENCHEN (999977463) DE811193231 participant HES € 994,511 € 994,511 € 994,511
Israel BEN-GURION UNIVERSITY OF THE NEGEV (999846222) IL500701644 coordinator HES € 1,297,300 € 1,297,300 € 1,297,300
Italy UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA (999987745) IT02133771002 participant HES € 1,063,781 € 1,063,781 € 1,063,781